Mark J. Ratain to Receptors, Vascular Endothelial Growth Factor
This is a "connection" page, showing publications Mark J. Ratain has written about Receptors, Vascular Endothelial Growth Factor.
Connection Strength
0.145
-
Sorafenib dose escalation is not uniformly associated with blood pressure elevations in normotensive patients with advanced malignancies. Clin Pharmacol Ther. 2014 Jul; 96(1):27-35.
Score: 0.115
-
Vatalanib population pharmacokinetics in patients with myelodysplastic syndrome: CALGB 10105 (Alliance). Br J Clin Pharmacol. 2014 Nov; 78(5):1005-13.
Score: 0.030